A recent investigation uncovered significant regulatory deficiencies within Morgan Stanley's wealth management operations.

Morgan Stanley says it's bullish on medtech in 2025 and upgraded Intuitive Surgical (ISRG), Tandem (TNDM), Stryker (SYK), ...

When Walmart CEO, Doug McMillon, needs a bottle of wine, he doesn’t have to wait long, thanks to a fleet of drones serving ...

Axon Enterprise (NASDAQ:AXON) on Tuesday was upgraded to Overweight from a previous investment rating of Equal Weight by ...

A former wealth manager contends she was unfairly denied disability payments after fibromyalgia and other health complaints ...

Shares of Morgan Stanley MS dropped 0.45% to $130.44 Tuesday, on what proved to be an all-around mixed trading session for ...

Evercore Inc. hired veteran health-care banker Joseph Modisett as a senior managing director, according to a person briefed ...

Keefe Bruyette raised the firm’s price target on Morgan Stanley (MS) to $138 from $121 and keeps a Market Perform rating on the shares. The U.S. bank stocks have had a strong run following better than ...

Morgan Stanley notes that BlackRock (BLK) has announced the acquisition of HPS Investment Partners for $12B in an all-stock transaction, ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $123.62, a high estimate of $142 ...

Internal company documents describe the bank’s weak anti-money-laundering controls and failure to complete due-diligence ...

Morgan Stanley got regulatory approval to locate its Middle East headquarters in Saudi Arabia, joining Wall Street rivals ...